Tag: non-high risk individuals

Antibody Ambivalence: Why the Constraints on Monoclonal Antibodies in COVID-19
February 10, 2021 Blog Post Snowfish

Despite an average vaccination rate of 1.41 million doses per day in the U.S, the pandemic continues to take its toll on the population. In our last post, my colleague wrote of his relative who unfortunately contracted coronavirus. However, we are pleased to inform that she received a monoclonal antibodies treatment, and is currently recovering.
Details